The purpose of this study was to assess the diagnostic value and potentially protective capacity of heat-shock protein 70 (HSP70) in chronic bacterial prostatitis and chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS). In this study, seminal plasma levels of cytokines (tumor necrosis factor-a (TNF-a) and interleukin 1b (IL-1b)) and HSP70 were evaluated by enzyme-linked immunosorbent assay in 80 men: 15 healthy controls, 16 men with chronic bacterial prostatitis, 23 men with CP/CPPS IIIA and 26 with CP/CPPS IIIB. The HSP70 levels in chronic bacterial prostatitis and CP/CPPS patients were correlated with chronic prostatitis symptom index (CPSI). Significantly increased levels of cytokines (TNF-a and IL-1b) and HSP70 were observed in seminal plasmas from patients with chronic bacterial prostatitis compared with CP/CPPS patients and controls. However, only IL-1b was significantly elevated compared with CP/CPPS IIIB and controls in patients with CP/CPPS IIIA. HSP70 levels in CP/CPPS patients were significantly lower than that in controls. HSP70 concentration in seminal plasma was negatively correlated with CPSI in chronic bacterial prostatitis. The results indicated that HSP70 and IL-1b appear to be the most reliable and predictive surrogate markers to diagnose chronic bacterial prostatitis and CP/CPPS, respectively. HSP70 has an important protective role in the regulation of cell functions in chronic bacterial prostatitis. CP/CPPS would probably be detrimental to the ability of T cells and consequently suppress the expression of HSP70.
Introduction
Epidemiological studies demonstrate that chronic prostatitis is a common disease that accounts for a quarter of all visits of male patients to urology clinics. About 50% of men suffer from this disease during their lifetime. 1, 2 The National Institutes of Health (NIH) consensus definition and classification identifies four categories of prostatitis:
3 category I includes acute bacterial prostatitis; category II is chronic bacterial prostatitis; category III, also known as chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS), is defined by pelvic pain in the absence of demonstrable bacterial infection, and is further subdivided into category IIIA (inflammatory) and category IIIB (noninflammatory), based on the presence of leukocytes in expressed prostatic secretions or seminal plasma; category IV, or asymptomatic inflammatory prostatitis, is defined by the presence of leukocytes in seminal secretions or by inflammatory infiltrates detected in histological specimens, in the absence of typical chronic pelvic pain. CP/CPPS is a common disease in adult men of unknown etiology. Neurological, immunological and endocrine dysfunctions have been proposed to be involved in the pathogenesis of this disease. 4 Recent studies have demonstrated that autoimmune components are involved in the pathogenesis of CP/CPPS. [5] [6] [7] [8] Heat-shock proteins (HSPs) are crucial for the maintenance of cell integrity during both normal cell growth and pathophysiological conditions. 9-12 By controlling binding and release, HSPs function mainly as molecular chaperones, which participate in the folding and assembly of nascent and unfolding proteins and facilitate protein transport to subcellular compartments. HSPs are classified into four major families according to their biological activities: HSP90, HSP70, HSP60 and small HSPs including HSP27. Although HSP60, HSP70 and HSP90 are constitutively expressed, HSP70 and HSP27 are induced by various conditions, including heat, bacterial toxins, oxidative stress or drug exposure. [13] [14] [15] The type of HSP induced and its level of expression can determine the fate of a cell in response to stress or stimulus. HSP70 is synthesized by cells in response to heat, as well as various other stressful stimuli associated with bacterial infections. It also has a role in protein homeostasis, thus maintaining vital cellular functions during periods of cellular distress, including bacterial infections. 16, 17 The specific role of HSP70 in stress tolerance has been elucidated in a number of studies. [18] [19] [20] [21] [22] In this study, we evaluated HSP70 expression in the seminal plasma of patients with chronic bacterial prostatitis, CP/CPPS and healthy controls, and focused on the variety in the expression of HSP70, which has different roles in the pathogenesis of chronic bacterial prostatitis and CP/CPPS.
Materials and methods

Patients
The population of this study consisted of 15 All subjects underwent a standard physical examination, including digital rectal examination. Urine and semen samples were subjected to microscopic analysis and cultured. To discriminate between patients with bacterial and nonbacterial chronic prostatitis, conventional and nonconventional bacterial cultures were obtained. We detected infection with known prostatic pathogens, including Escherichia coli, Staphylococcus aureus, Klebsiella, Chlamydia trachomatis, Candida albicans and Trichomonas in 16 patients with bacterial chronic prostatitis. The presence of leukocytes in expressed prostatic secretion was used to differentiate between patients with CP/CPPS IIIA (410 white blood cells per high-power field, WBC/HP, n ¼ 23) and IIIB (o10 WBC/HP, n ¼ 26); urine and semen cultures must be negative for a patient to be classified in either of these categories. Cultures were negative in all the 15 age-matched volunteers with no history of genitourinary disease who served as controls.
All subjects answered Chinese versions of the NIH-chronic prostatitis symptom index (NIH-CPSI) questionnaire (mean±s.d.: 20.8±5.7), which scored the symptoms on the domains of pain, urinary symptoms and quality of life. Inclusion criteria for CP/CPPS patients were chronic genital or pelvic pain for at least 3 of the preceding 6 months in the absence of other identifiable causes, an NIH-CPSI total score of X12 (scale of 0-43) and a nonzero pain score. In addition to an NIH-CPSI score of 0, the controls were required to have no pain, a PSA level of o2.5 ng ml À1 and normal digital rectal examination findings. We excluded subjects who had taken antibiotics, nonsteroidal anti-inflammatory drugs or steroids in the last 2 months.
Cytokines in seminal plasma
Semen samples were collected directly into a sterile container by masturbation after 2-7 days of sexual abstinence. Seminal plasma samples were collected after centrifugation at 3000 r.p.m. for 15 min. Tumor necrosis factor-a (TNF-a) and interleukin 1b (IL-1b) were assayed in seminal plasma by an enzyme-linked immunosorbent assay Kit (Invitrogen, Biosource, Nivelles, Belgium). The assay was performed according to the manufacturer's instructions. The cytokine contents were expressed in pgml À1 , according to standard curves ranging from 1.7 to 1000 pg ml À1 for TNF-a and from 1.5 to 1000 pg ml
À1
for IL-1b. Optical density was measured at 450 nm.
HSP70 in seminal plasma
The HSP70 enzyme-linked immunosorbent assay Kit (Stressgen Biotechnologies, Victoria, Canada) was performed according to the supplier's instructions. The assay can detect HSP70 levels in the range of 0.78-50 ng ml
À1
. The absolute concentration of HSP70 was calculated based on the HSP70 standard curve. Optical density was measured at 450 nm.
Statistical analysis
The data were expressed as mean±s.e.m. Statistical analyses were performed using the one-way analysis of variance, whenever appropriate. We applied Spearman's correlation analysis to assess the associations among different parameters. Statistically significance was considered to be Po0.05. All statistical analyses were performed on SPSS for Windows 12.0 (SPSS China Company, Shanghai, China).
Results
TNF-a and IL-1b expression in seminal plasma
Seminal plasma levels of TNF-a and IL-1b were significantly higher in patients with chronic bacterial prostatitis compared with those with CP/CPPS IIIA (P TNF-a o0. 001, P IL-1b ¼ 0.006), IIIB (P TNF-a o0.001, P IL-1b o0.001) and controls (P TNF-a o0.001, P IL-1b o0.001). The different expression of TNF-a in CP/CPPS IIIA, IIIB and controls were not significant (P40.05). IL-1b levels in patients with CP/CPPS IIIA were significantly higher than that in CP/CPPS IIIB and controls (Po0.001, Po0.001, respectively). Whereas, compared to controls, there was slightly increased IL-1b secretion in CP/CPPS IIIB, although this result was not statistically significant (P ¼ 0.07; Figure 1 ). 
HSP70 expression in seminal plasma
The HSP70 expression in patients with chronic bacterial prostatitis was higher than in patients with CP/CPPS IIIA, IIIB and control subjects (Po0.001, Po0.001, Po0.001, respectively). Compared to controls, the HSP70 expression was significantly decreased in patients with CP/CPPS IIIA (Po0.001) and IIIB (Po0.001). Although levels of HSP70 in the CP/CPPS IIIA are slightly higher than that in CP/CPPS IIIB, this result was not statistically significant (P ¼ 0.902; Figure 1 ).
Correlation between HSP70 and symptom score in patients with chronic bacterial prostatitis and CP/CPPS All patients completed the Chinese versions of the NIH-CPSI. HSP70 levels in chronic bacterial prostatitis patients show a negative association with the NIH-CPSI total score (r ¼ À0.801; Po0.001). The expression of HSP70 did not correlate with total NIH-CPSI scores in CP/CPPS IIIA (r ¼ À0.052; P ¼ 0.815) or IIIB patients (r ¼ 0.037; P ¼ 0.858).
Discussion
The pathogenesis of the chronic bacterial prostatitis is associated with various bacterial infections and prostatic inflammation. The most common etiological organisms are E. coli, which accounts for 80% of cases of chronic bacterial prostatitis, and other members of the Enterobacteriaceae family. CP/CPPS is a common diagnosis but very little is understood about the etiology and pathogenesis of the disease. 23 A large body of evidence accumulated over many years has failed to provide convincing proof that some fastidious organisms are responsible for symptoms in a significant proportion of men who present with symptoms of CP/CPPS. Recently, several groups reported that autoimmune response against the inflammatory process involved may have an important role in the pathogenesis of CP/CPPS. [24] [25] [26] It has been well demonstrated that HSP70, also called stress protein, may participate in the cellular response to hyperthermia, ischemic injury, infection and autoimmune diseases. [27] [28] [29] [30] The protein serves as a chaperone molecule for various intracellular proteins and may alter their functional characteristics. The induction of HSP70 expression by bacterial infection has a role in the cellular response to injury. HSP70 has the ability to protect cells from the deleterious effects of inflammation; for example, by refolding and stabilizing denatured protein aggregates. 31 In this study, we found that inflammatory cytokines (TNF-a and IL-1b) and HSP70 synthesis were significantly increased in chronic bacterial prostatitis. This finding is similar to earlier studies of other inflammation diseases, which showed that levels of the inflammatory cytokine IL-1b and HSP70 are both increased in rats infected with E. coli. 32 Chronic bacterial prostatitis is a typical chronic inflammation disease. When mononuclear and macrophages phagocytes recognize bacterium through their cell-surface receptors, they release numerous inflammatory cytokines that induce inflammation to control the bacterial invaders. HSP70 is actively synthesized when monocytes and macrophages are exposed to bacterial toxins. Excessive production of HSP70 during bacterial invasions appears to increase the host defense against bacterial infection. This concept was supported by a series of findings, including the observation that increased HSP expression protected macrophages from cytotoxicity caused by S. aureus,
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Lactobacillus 34 and Salmonella. 35 It is noteworthy that HSP70 provided important cellular protection capacity in the regulation of cell functions in chronic bacterial prostatitis.
The HSP70 expression depend on the normal and maturity immune system. Nagasawa et al. 36 and Hirsh and Junger 37 report that high and stable expression of HSP70 is required for normal development and function of natural regulatory T cells in humans. The low expression of HSP70 has been described in association with autoimmunity. In this study, we observed lower HSP70 expression levels in CP/CPPS patients compared with healthy controls. Thus, it is tempting to speculate that the suppression of HSP70 expression may attribute to the cellular dysfunction of immunocompetent cells concerning antigen presentation, phagocytosis and antibody production associated with decreased resistance to infectious insults during the CP/CPPS. CP/CPPS may disrupt the ability of T cells to suppress the immune system and consequently decrease HSP70 expression in these patients. On the other hand, it is further proved that the CP/CPPS is a kind of immune disease. Autoimmune may have a prominent role in the induction and progression of CP/CPPS.
We demonstrated significantly increased IL-1b levels in seminal plasma of patients with CP/CPPS IIIA compared with CP/CPPS IIIB. This finding indicates that inflammatory factors participate in the regulation of IL-1b production in CP/CPPS IIIA patients. We propose that the increase in IL-1b expression in CP/CPPS IIIA patients is consistent with a chronic inflammatory process in the pathogenesis of this diseases. Nevertheless, this inflammatory response is just in the secondary and synergistic position rather than autoimmune response, which is the dominant position in the induction and progression of CP/CPPS IIIA. Owing to the changes of IL-1b expression between CP/ CPPS IIIA and CP/CPPS IIIB, it seems reasonable to suggest that measurements of IL-1b expression can discriminate between patients with CP/CPPS IIIA and CP/CPPS IIIB.
Moreover, our data demonstrated that HSP70 expression in seminal plasma correlates negatively with total NIH-CPSI scores in patients with chronic bacterial prostatitis. Thus, HSP70 levels may be suggested to assess the severity of prostatic inflammation in these patients. The expression of HSP70 did not correlate with the NIH-CPSI total scores in CP/CPPS patients, which suggests that HSP70 is not a reliable indicator of the subtype or severity of CP/CPPS. These results clearly indicate that inflammatory component is critically involved in the pathogenesis of chronic bacterial prostatitis. Men with chronic bacterial prostatitis present with irritative voiding symptoms and perigenital pain that primarily result from the bacterial infection and prostatic inflammation. These symptoms in CP/CPPS patients, however, may attribute to many other etiologies, such as autoimmune, neuromuscular dysfunction, autonomic HSP 70 expression in the seminal plasma H Guo et al nerve functional disturbances and chemical inflammation secondary to the reflux of urine.
Once the ability of HSP70 to protect cells from the deleterious effects of inflammation are understood, therapeutic applications for the treatment of chronic bacterial prostatitis can be explored. Khan et al. 38 report that HSPs can directly activate cytotoxic T lymphocytes without the assistance of T h cells, which might be very useful in eliciting an immune response even in immunocompromised individuals. Given that defects in HSP70 quantity and function are one of the major causes of immune disorders in CP/CPPS, increasing and enhancing of HSP70 quantity and function holds great therapeutic potential. Restoration of an adequate cellular HSP70 response may be the goal of future studies. It should be novel treatments for chronic bacterial prostatitis and CP/CPPS and merit further study by enhancing HSP70 expression and exogenous HSP70 administration.
In conclusion, HSP70 and IL-1b are measurable in human semen plasma and they provide useful information in diagnosing prostatic inflammatory conditions and categorizing CPPS III subclasses, respectively. Levels of HSP70 expression are feasible to regard as diagnosis and prognostic indicators for chronic bacterial prostatitis. IL-1b appears to represent a useful biomarker in CP/CPPS and can be used to discriminate CP/CPPS IIIA from IIIB. Enhancing HSP70 expression in chronic bacterial prostatitis and CP/CPPS may have important therapeutic applications.
